# Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL

> **NCT06406556** · PHASE2 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 90 (estimated)

## Conditions studied

- Extranodal NK/T-cell Lymphoma

## Interventions

- **COMBINATION_PRODUCT:** Pegaspargase combined with concurrent radiotherapy.

## Key facts

- **NCT ID:** NCT06406556
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-03-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06406556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06406556, "Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT06406556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*